Cartesian Therapeutics Inc
NASDAQ:RNAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cartesian Therapeutics Inc
NASDAQ:RNAC
|
US |
Intrinsic Value
The intrinsic value of one
RNAC
stock under the Base Case scenario is
1.54
USD.
Compared to the current market price of 6.39 USD,
Cartesian Therapeutics Inc
is
Overvalued by 76%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Cartesian Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Cartesian Therapeutics Inc
Earnings Waterfall
Cartesian Therapeutics Inc
The intrinsic value of one
RNAC
stock under the Base Case scenario is
1.54
USD.
Compared to the current market price of 6.39 USD,
Cartesian Therapeutics Inc
is
Overvalued by 76%.